Distinguished in COVID-19

Dr. Todd Rice

Intensive Care Medicine
Vanderbilt University
3601 21st Ave S, 
Nashville, TN 
Offers Telehealth
Distinguished in COVID-19
Vanderbilt University
3601 21st Ave S, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Todd Rice is an Intensive Care Medicine provider in Nashville, Tennessee. Dr. Rice is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cerebral Hypoxia, COVID-19, Severe Acute Respiratory Syndrome (SARS), Endoscopy, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 351 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 67 articles and participated in 3 clinical trials in the study of COVID-19.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in TN
Hospital Affiliations
Vanderbilt University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alliant Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

Vanderbilt University
3601 21st Ave S, Nashville, TN 37232

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Enrollment Status: Completed
Publish Date: December 24, 2024
Intervention Type: Drug
Study Phase: Phase 2
Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19
Trial of Early Therapies During Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Other, Drug
Study Drug: Lopinavir
Study Phase: Phase 2
Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects With Recently Diagnosed COVID-19 Compared to Standard of Care Treatment
Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Antiviral Activity of BLD-2660 in Hospitalized Subjects With Recently Diagnosed COVID-19 Compared to Standard of Care Treatment
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Drug: BLD-2660
Study Phase: Phase 2
The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry-based Randomized Trial
The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Registry-based Randomized Trial
Enrollment Status: Completed
Publish Date: March 28, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
Enrollment Status: Completed
Publish Date: December 16, 2019
Intervention Type: Other
Study Phase: Not Applicable
Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Isotonic Solutions and Major Adverse Renal Events Trial in Non-Medical Intensive Care Units
Enrollment Status: Completed
Publish Date: November 25, 2019
Intervention Type: Other
Study Phase: Not Applicable
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Enrollment Status: Completed
Publish Date: September 13, 2018
Intervention Type: Other
Study Phase: Not Applicable
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
Enrollment Status: Completed
Publish Date: January 26, 2018
Intervention Type: Other
Study Phase: Not Applicable
Scanning of Bilateral Internal Jugular Veins With Ultrasound Prior to CVC Placement - Effect on Success and Complications
Scanning of Bilateral Internal Jugular Veins With Ultrasound Prior to CVC Placement - Effect on Success and Complications
Enrollment Status: Completed
Publish Date: July 14, 2017
Intervention Type: Procedure
Study Phase: Not Applicable
View 9 Less Clinical Trials

349 Total Publications

Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults.
Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults.
Journal: The New England journal of medicine
Published: December 10, 2025
Similar Doctors
Distinguished in COVID-19
Dr. Jonathan Casey
Intensive Care Medicine
Distinguished in COVID-19
Dr. Jonathan Casey
Intensive Care Medicine

Vanderbilt University Transplant Center

1161 21st Ave S, 
Nashville, TN 
 (0.3 miles away)
615-322-3412
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Casey is an Intensive Care Medicine provider in Nashville, Tennessee. Dr. Casey is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cerebral Hypoxia, COVID-19, Severe Acute Respiratory Syndrome (SARS), Advanced Bronchoscopy, and Endoscopy.

Matthew Semler
Advanced in COVID-19
Dr. Matthew Semler
Intensive Care Medicine
Advanced in COVID-19
Dr. Matthew Semler
Intensive Care Medicine

Vanderbilt University Medical Center

1211 Medical Center Dr, 
Nashville, TN 
 (0.1 miles away)
615-322-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Matthew Semler is an Intensive Care Medicine provider in Nashville, Tennessee. Dr. Semler is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Endoscopy.

Advanced in COVID-19
Dr. Stacey Vallejo
Intensive Care Medicine
Advanced in COVID-19
Dr. Stacey Vallejo
Intensive Care Medicine

Advanced Diagnostic Imaging PC

4230 Harding Pike Ste 503, 
Nashville, TN 
 (4.3 miles away)
615-297-2700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stacey Vallejo is an Intensive Care Medicine provider in Nashville, Tennessee. Dr. Vallejo is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Cerebral Hypoxia, Lung Metastases, Pneumonia, and Chronic Obstructive Pulmonary Disease (COPD).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rice's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile